Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers.
On a global scale, the Neurological Biomarkers market is currently showing significant development. The Neurological Biomarkers market is experiencing a growth velocity due to the new product prototype versions, world market dynamics, topological variations, economic statistics, product demands and ... Read more
The Neurological Biomarkers Market is estimated to be valued at US$ 11813.64 Mn in 2023 and is expected to exhibit a CAGR of 14% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Neurological biomarkers help in identifying biological changes in the brain associated with neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These biomarkers help in early disease diagnosis and prediction of disease progression through minimally invasive procedures such as MRI scans, analysis of cerebrospinal fluid and blood tests. The use of neurological biomarkers is increasing due to rising prevalence of neurological diseases globally, ... Read more
Neurological biomarkers are used for diagnosis of various neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These biomarkers help in measuring changes in the brain due to neurological conditions. They are indicator or substance that can be detected in body fluids such as cerebrospinal fluid, blood, and urine and tissues. Neurological biomarkers play an important role in developing novel therapies by identifying potential drug targets.
Neurological biomarkers help in early diagnosis and better management of neurological diseases like Alzheimer's disease, Parkinson's disease and various types of brain cancer. Biomarkers play an important role in developing personalized treatment strategies. The growing focus on precision medicine is driving the demand for neurological biomarkers to develop targeted therapies. Biomarkers help identify individuals who are more likely to benefit from specific drugs and therapies. This is ... Read more
